Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression

Cuncan Deng,Mingyu Huo,Hongwu Chu,Xiaomei Zhuang,Guofei Deng,Wenchao Li,Hongfa Wei,Leli Zeng,Yulong He,Huashan Liu,Jia Li,Changhua Zhang,Hengxing Chen
DOI: https://doi.org/10.1186/s12943-024-01966-4
IF: 37.3
2024-03-09
Molecular Cancer
Abstract:Circular RNAs (circRNAs) play important roles in gastric cancer progression but the regulatory role of circRNAs in controlling macrophage function remains elusive. Exosomes serve as cargo for circRNAs and play a crucial role as mediators in facilitating communication between cancer cells and the tumor microenvironment. In this study, we found that circATP8A1, a previously unreported circular RNA, is highly expressed in both gastric cancer tissues and exosomes derived from plasma. Increased circATP8A1 was associated with advanced TNM stage and worse prognosis in patients with gastric cancer. We showed that the circATP8A1 knockdown significantly inhibited gastric cancer proliferation and invasion in vitro and in vivo. Functionally, exosome circATP8A1 induced the M2 polarization of macrophages through the STAT6 pathway instead of the STAT3 pathway. Mechanistically, circATP8A1 was shown to activate the STAT6 pathway through competitive binding to miR-1-3p, as confirmed by Fluorescence In Situ Hybridization (FISH), RNA immunoprecipitation, RNA pulldown, and Luciferase reporter assays. The reversal of circATP8A1-induced STAT6 pathway activation and macrophage polarization was observed upon blocking miR-1-3p. Macrophages treated with exosomes from gastric cancer cells overexpressing circATP8A1 were able to promote gastric cancer migration, while knockdown of circATP8A1 reversed these effects in vivo. In summary, exosome-derived circATP8A1 from gastric cancer cells induce macrophages M2 polarization via the circATP8A1/miR-1-3p/STAT6 axis, and tumor progression. Our results highlight circATP8A1 as a potential prognostic biomarker and therapeutic target in gastric cancer.
oncology,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the role of circular RNA (circRNA) in exosomes in the progression of gastric cancer, specifically how circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis, thereby promoting the development of gastric cancer. Specifically, the researchers found that circATP8A1 is highly expressed in exosomes and is associated with advanced TNM staging and poor prognosis in gastric cancer patients. They further explored the function of circATP8A1 in gastric cancer cells and how it affects the polarization state of macrophages after being transferred to them via exosomes, ultimately promoting the progression of gastric cancer. The main research contents include: 1. **Identification and validation of circATP8A1**: Through circRNA microarray analysis, differentially expressed circRNAs in the plasma exosomes of gastric cancer patients were identified, and circATP8A1 was found to be significantly highly expressed in exosomes. 2. **Functional study of circATP8A1**: Through in vitro and in vivo experiments, it was demonstrated that knockdown of circATP8A1 can significantly inhibit the proliferation and invasion of gastric cancer cells. 3. **Effect of circATP8A1 on macrophages**: The study showed that circATP8A1 in exosomes can competitively bind to miR-1-3p, activate the STAT6 pathway, induce macrophage M2 polarization, and thus promote the development of gastric cancer. 4. **Mechanism exploration**: Using various experimental techniques (such as fluorescence in situ hybridization, RNA immunoprecipitation, RNA pulldown, and luciferase reporter assays), the specific mechanism by which circATP8A1 regulates the STAT6 pathway through competitive binding to miR-1-3p was revealed. In summary, this paper aims to reveal the role of circATP8A1 in exosomes and its impact on the progression of gastric cancer, providing new potential targets for the early diagnosis and treatment of gastric cancer.